In cases with PBC, serum omentin-1 presented negative associations with tumor biomarkers (CA15-3 and CEA), inflammatory biomarkers (hsCRP, TNF-α, and IL-6), and clinicopathologic features such as stage and the number of infiltrated lymph nodes (p < 0.05). This evidence concerns the gene CEACAM5 and neoplasm.